The machine learning methods to analyze the using strategy of antiplatelet drugs in ischaemic stroke patients with gastrointestinal haemorrhage [PDF]
BMC Neurology, 2023 Background For ischaemic stroke patients with gastrointestinal haemorrhage, stopping antiplatelet drugs or reducing the dose of antiplatelet drugs was a conventional clinical therapy method. But not a study to prove which way was better.
Chaohua Cui +4 more
doaj +2 more sources
The Impact of Preinjury Use of Antiplatelet Drugs on Outcomes of Traumatic Brain Injury: A Systematic Review and Meta-Analysis [PDF]
Frontiers in Neurology, 2022 ObjectiveThe study aimed to compare outcomes of traumatic brain injury (TBI) in patients on pre-injury antiplatelet drugs vs. those, not on any antiplatelet or anticoagulant drugs.MethodsPubMed, Embase, and Google Scholar databases were searched up to ...
Li Cheng, Gaoliang Cui, Rong Yang
doaj +2 more sources
High-throughput combinatorial screening of antiplatelet drugs for personalized medicine [PDF]
Microsystems & NanoengineeringCardiovascular disease (CVD) remains the leading cause of death worldwide. Platelet activation plays a critical role in arterial thrombotic events such as myocardial infarction. Although antiplatelet drugs are standard therapies, they are associated with
Chenguang Wang +9 more
doaj +2 more sources
Efficacy and safety of new oral anticoagulants combined with antiplatelet drugs in the treatment of coronary heart disease: Systematic evaluation and meta‐analysis [PDF]
Annals of Noninvasive Electrocardiology, 2022 Objective To analyze the efficacy and safety of antiplatelet drugs combined with new oral anticoagulants (noac) in the treatment of coronary atherosclerotic heart disease (CAD).
Alimila Saiyitijiang +3 more
doaj +2 more sources
Influence of antiplatelet drugs on gastric ulcer healing after endoscopic submucosal dissection in patients with early gastric cancer [PDF]
DEN OpenObjectives The causes of drug‐induced gastroduodenal injuries primarily include antithrombotic drugs, including low‐dose aspirin, non‐steroidal anti‐inflammatory drugs, and corticosteroids.
Kazuto Takahashi +10 more
doaj +2 more sources
Coming safely to a stop: a review of platelet activity after cessation of antiplatelet drugs [PDF]
, 2015 Funding Isobel Ford is an employee of the University of Aberdeen. The research for the writing of this review received no specific grant from any funding agency in the public, commercial, or not-forprofit sectorsPeer ...
I. Ford
openalex +3 more sources
Antithrombotic Effects of Fostamatinib in Combination with Conventional Antiplatelet Drugs. [PDF]
Int J Mol Sci, 2022 Harbi MH +6 more
europepmc +3 more sources
Patients with metabolic dysfunction-associated steatotic liver disease have preserved in vitro responses to antiplatelet drugs. [PDF]
Res Pract Thromb Haemost, 2023 van den Boom BP +4 more
europepmc +3 more sources
Antiplatelet drugs: a review of pharmacology and the perioperative management of patients in oral and maxillofacial surgery. [PDF]
Ann R Coll Surg Engl, 2020 Mahmood H, Siddique I, McKechnie A.
europepmc +3 more sources
DENTAL MANAGEMENT AND BLEEDING COMPLICATIONS OF PATIENTS ON LONG-TERM ORAL ANTIPLATELET THERAPY. REVIEW OF EXISTING STUDIES AND GUIDELINES. [PDF]
Journal of IMAB, 2013 Antiplatelet drugs are currently widely used in primary and especially secondary prevention of cardiovascular events. Dental management of patients on antiplatelet therapy is still not clearly defined: the discontinuation of antiplatelet therapy ...
Atanaska Dinkova +2 more
doaj +1 more source